 | • レポートコード：MRC2-11QY04021 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は核酸ベース治療薬のグローバル市場について調査・分析したレポートです。種類別（アンチセンスおよびアンチジーン、短期阻害配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、アプタマー）市場規模、用途別（単遺伝性障害、多遺伝子性障害）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別核酸ベース治療薬の競争状況、市場シェア ・世界の核酸ベース治療薬市場：種類別市場規模 2015年-2020年（アンチセンスおよびアンチジーン、短期阻害配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、アプタマー） ・世界の核酸ベース治療薬市場：種類別市場規模予測 2021年-2026年（アンチセンスおよびアンチジーン、短期阻害配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、アプタマー） ・世界の核酸ベース治療薬市場：用途別市場規模 2015年-2020年（単遺伝性障害、多遺伝子性障害） ・世界の核酸ベース治療薬市場：用途別市場規模予測 2021年-2026年（単遺伝性障害、多遺伝子性障害） ・北米の核酸ベース治療薬市場分析：米国、カナダ ・ヨーロッパの核酸ベース治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの核酸ベース治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の核酸ベース治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの核酸ベース治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Wave Life Sciences、Imugene、Caperna、Phylogica、Protagonist Therapeutics、Benitec Biopharma、EGEN、BioMedica、Transgene、Copernicus Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
Although most of the nucleic acid-based drugs are in early stages of clinical trials, these classes of compounds have emerged in recent years to yield extremely promising candidates for drug therapy to a wide range of diseases, including cancer, infectious diseases, diabetes, cardiovascular, inflammatory, and neurodegenerative diseases, cystic fibrosis, hemophilia, and other genetic disorders.
Market Analysis and Insights: Global Nucleic Acid-based Therapeutics Market
The global Nucleic Acid-based Therapeutics market size is projected to reach US$ 541.1 million by 2026, from US$ 519.4 million in 2020, at a CAGR of 3.9%% during 2021-2026.
Global Nucleic Acid-based Therapeutics Scope and Market Size
Nucleic Acid-based Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nucleic Acid-based Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
Benitec Biopharma
EGEN
BioMedica
Transgene
Copernicus Therapeutics
Market segment by Type, the product can be split into
Anti-Sense And Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Market segment by Application, split into
Monogenetic Disorders
Multi-Genetic Disorders
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nucleic Acid-based Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-Sense And Anti-Gene
1.4.3 Short Inhibitory Sequences
1.4.4 Gene Transfer Therapy
1.4.5 Nucleoside Analogs
1.4.6 Ribozymes
1.4.7 Aptamers
1.5 Market by Application
1.5.1 Global Nucleic Acid-based Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Monogenetic Disorders
1.5.3 Multi-Genetic Disorders
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid-based Therapeutics Market Perspective (2015-2026)
2.2 Global Nucleic Acid-based Therapeutics Growth Trends by Regions
2.2.1 Nucleic Acid-based Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Nucleic Acid-based Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Nucleic Acid-based Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nucleic Acid-based Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Nucleic Acid-based Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid-based Therapeutics Players by Market Size
3.1.1 Global Top Nucleic Acid-based Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Nucleic Acid-based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nucleic Acid-based Therapeutics Market Concentration Ratio
3.2.1 Global Nucleic Acid-based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nucleic Acid-based Therapeutics Revenue in 2019
3.3 Nucleic Acid-based Therapeutics Key Players Head office and Area Served
3.4 Key Players Nucleic Acid-based Therapeutics Product Solution and Service
3.5 Date of Enter into Nucleic Acid-based Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nucleic Acid-based Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)
5.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Nucleic Acid-based Therapeutics Market Size (2015-2020)
6.2 Nucleic Acid-based Therapeutics Key Players in North America (2019-2020)
6.3 North America Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
6.4 North America Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Nucleic Acid-based Therapeutics Market Size (2015-2020)
7.2 Nucleic Acid-based Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
7.4 Europe Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Nucleic Acid-based Therapeutics Market Size (2015-2020)
8.2 Nucleic Acid-based Therapeutics Key Players in China (2019-2020)
8.3 China Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
8.4 China Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Nucleic Acid-based Therapeutics Market Size (2015-2020)
9.2 Nucleic Acid-based Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
9.4 Japan Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Nucleic Acid-based Therapeutics Market Size (2015-2020)
10.2 Nucleic Acid-based Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Nucleic Acid-based Therapeutics Market Size (2015-2020)
11.2 Nucleic Acid-based Therapeutics Key Players in India (2019-2020)
11.3 India Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
11.4 India Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Nucleic Acid-based Therapeutics Market Size (2015-2020)
12.2 Nucleic Acid-based Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Nucleic Acid-based Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Nucleic Acid-based Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Wave Life Sciences
13.1.1 Wave Life Sciences Company Details
13.1.2 Wave Life Sciences Business Overview
13.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Introduction
13.1.4 Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2015-2020))
13.1.5 Wave Life Sciences Recent Development
13.2 Imugene
13.2.1 Imugene Company Details
13.2.2 Imugene Business Overview
13.2.3 Imugene Nucleic Acid-based Therapeutics Introduction
13.2.4 Imugene Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
13.2.5 Imugene Recent Development
13.3 Caperna
13.3.1 Caperna Company Details
13.3.2 Caperna Business Overview
13.3.3 Caperna Nucleic Acid-based Therapeutics Introduction
13.3.4 Caperna Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
13.3.5 Caperna Recent Development
13.4 Phylogica
13.4.1 Phylogica Company Details
13.4.2 Phylogica Business Overview
13.4.3 Phylogica Nucleic Acid-based Therapeutics Introduction
13.4.4 Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
13.4.5 Phylogica Recent Development
13.5 Protagonist Therapeutics
13.5.1 Protagonist Therapeutics Company Details
13.5.2 Protagonist Therapeutics Business Overview
13.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Introduction
13.5.4 Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
13.5.5 Protagonist Therapeutics Recent Development
13.6 Benitec Biopharma
13.6.1 Benitec Biopharma Company Details
13.6.2 Benitec Biopharma Business Overview
13.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Introduction
13.6.4 Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
13.6.5 Benitec Biopharma Recent Development
13.7 EGEN
13.7.1 EGEN Company Details
13.7.2 EGEN Business Overview
13.7.3 EGEN Nucleic Acid-based Therapeutics Introduction
13.7.4 EGEN Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
13.7.5 EGEN Recent Development
13.8 BioMedica
13.8.1 BioMedica Company Details
13.8.2 BioMedica Business Overview
13.8.3 BioMedica Nucleic Acid-based Therapeutics Introduction
13.8.4 BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
13.8.5 BioMedica Recent Development
13.9 Transgene
13.9.1 Transgene Company Details
13.9.2 Transgene Business Overview
13.9.3 Transgene Nucleic Acid-based Therapeutics Introduction
13.9.4 Transgene Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
13.9.5 Transgene Recent Development
13.10 Copernicus Therapeutics
13.10.1 Copernicus Therapeutics Company Details
13.10.2 Copernicus Therapeutics Business Overview
13.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Introduction
13.10.4 Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2015-2020)
13.10.5 Copernicus Therapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Nucleic Acid-based Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Nucleic Acid-based Therapeutics Revenue
Table 3. Ranking of Global Top Nucleic Acid-based Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anti-Sense And Anti-Gene
Table 6. Key Players of Short Inhibitory Sequences
Table 7. Key Players of Gene Transfer Therapy
Table 8. Key Players of Nucleoside Analogs
Table 9. Key Players of Ribozymes
Table 10. Key Players of Aptamers
Table 11. Global Nucleic Acid-based Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Nucleic Acid-based Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Nucleic Acid-based Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Nucleic Acid-based Therapeutics Market Share by Regions (2015-2020)
Table 15. Global Nucleic Acid-based Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Nucleic Acid-based Therapeutics Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Nucleic Acid-based Therapeutics Market Growth Strategy
Table 21. Main Points Interviewed from Key Nucleic Acid-based Therapeutics Players
Table 22. Global Nucleic Acid-based Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 23. Global Nucleic Acid-based Therapeutics Market Share by Players (2015-2020)
Table 24. Global Top Nucleic Acid-based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nucleic Acid-based Therapeutics as of 2019)
Table 25. Global Nucleic Acid-based Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Nucleic Acid-based Therapeutics Product Solution and Service
Table 28. Date of Enter into Nucleic Acid-based Therapeutics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Nucleic Acid-based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 31. Global Nucleic Acid-based Therapeutics Market Size Share by Type (2015-2020)
Table 32. Global Nucleic Acid-based Therapeutics Revenue Market Share by Type (2021-2026)
Table 33. Global Nucleic Acid-based Therapeutics Market Size Share by Application (2015-2020)
Table 34. Global Nucleic Acid-based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 35. Global Nucleic Acid-based Therapeutics Market Size Share by Application (2021-2026)
Table 36. North America Key Players Nucleic Acid-based Therapeutics Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Nucleic Acid-based Therapeutics Market Share (2019-2020)
Table 38. North America Nucleic Acid-based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 39. North America Nucleic Acid-based Therapeutics Market Share by Type (2015-2020)
Table 40. North America Nucleic Acid-based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. North America Nucleic Acid-based Therapeutics Market Share by Application (2015-2020)
Table 42. Europe Key Players Nucleic Acid-based Therapeutics Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Nucleic Acid-based Therapeutics Market Share (2019-2020)
Table 44. Europe Nucleic Acid-based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Nucleic Acid-based Therapeutics Market Share by Type (2015-2020)
Table 46. Europe Nucleic Acid-based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Nucleic Acid-based Therapeutics Market Share by Application (2015-2020)
Table 48. China Key Players Nucleic Acid-based Therapeutics Revenue (2019-2020) (Million US$)
Table 49. China Key Players Nucleic Acid-based Therapeutics Market Share (2019-2020)
Table 50. China Nucleic Acid-based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. China Nucleic Acid-based Therapeutics Market Share by Type (2015-2020)
Table 52. China Nucleic Acid-based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. China Nucleic Acid-based Therapeutics Market Share by Application (2015-2020)
Table 54. Japan Key Players Nucleic Acid-based Therapeutics Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Nucleic Acid-based Therapeutics Market Share (2019-2020)
Table 56. Japan Nucleic Acid-based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Nucleic Acid-based Therapeutics Market Share by Type (2015-2020)
Table 58. Japan Nucleic Acid-based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Nucleic Acid-based Therapeutics Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Nucleic Acid-based Therapeutics Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Nucleic Acid-based Therapeutics Market Share (2019-2020)
Table 62. Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Nucleic Acid-based Therapeutics Market Share by Type (2015-2020)
Table 64. Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Nucleic Acid-based Therapeutics Market Share by Application (2015-2020)
Table 66. India Key Players Nucleic Acid-based Therapeutics Revenue (2019-2020) (Million US$)
Table 67. India Key Players Nucleic Acid-based Therapeutics Market Share (2019-2020)
Table 68. India Nucleic Acid-based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 69. India Nucleic Acid-based Therapeutics Market Share by Type (2015-2020)
Table 70. India Nucleic Acid-based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 71. India Nucleic Acid-based Therapeutics Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Nucleic Acid-based Therapeutics Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Nucleic Acid-based Therapeutics Market Share (2019-2020)
Table 74. Central & South America Nucleic Acid-based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Nucleic Acid-based Therapeutics Market Share by Type (2015-2020)
Table 76. Central & South America Nucleic Acid-based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Nucleic Acid-based Therapeutics Market Share by Application (2015-2020)
Table 78. Wave Life Sciences Company Details
Table 79. Wave Life Sciences Business Overview
Table 80. Wave Life Sciences Product
Table 81. Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2015-2020) (Million US$)
Table 82. Wave Life Sciences Recent Development
Table 83. Imugene Company Details
Table 84. Imugene Business Overview
Table 85. Imugene Product
Table 86. Imugene Revenue in Nucleic Acid-based Therapeutics Business (2015-2020) (Million US$)
Table 87. Imugene Recent Development
Table 88. Caperna Company Details
Table 89. Caperna Business Overview
Table 90. Caperna Product
Table 91. Caperna Revenue in Nucleic Acid-based Therapeutics Business (2015-2020) (Million US$)
Table 92. Caperna Recent Development
Table 93. Phylogica Company Details
Table 94. Phylogica Business Overview
Table 95. Phylogica Product
Table 96. Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2015-2020) (Million US$)
Table 97. Phylogica Recent Development
Table 98. Protagonist Therapeutics Company Details
Table 99. Protagonist Therapeutics Business Overview
Table 100. Protagonist Therapeutics Product
Table 101. Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2015-2020) (Million US$)
Table 102. Protagonist Therapeutics Recent Development
Table 103. Benitec Biopharma Company Details
Table 104. Benitec Biopharma Business Overview
Table 105. Benitec Biopharma Product
Table 106. Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2015-2020) (Million US$)
Table 107. Benitec Biopharma Recent Development
Table 108. EGEN Company Details
Table 109. EGEN Business Overview
Table 110. EGEN Product
Table 111. EGEN Revenue in Nucleic Acid-based Therapeutics Business (2015-2020) (Million US$)
Table 112. EGEN Recent Development
Table 113. BioMedica Business Overview
Table 114. BioMedica Product
Table 115. BioMedica Company Details
Table 116. BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2015-2020) (Million US$)
Table 117. BioMedica Recent Development
Table 118. Transgene Company Details
Table 119. Transgene Business Overview
Table 120. Transgene Product
Table 121. Transgene Revenue in Nucleic Acid-based Therapeutics Business (2015-2020) (Million US$)
Table 122. Transgene Recent Development
Table 123. Copernicus Therapeutics Company Details
Table 124. Copernicus Therapeutics Business Overview
Table 125. Copernicus Therapeutics Product
Table 126. Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2015-2020) (Million US$)
Table 127. Copernicus Therapeutics Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid-based Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Anti-Sense And Anti-Gene Features
Figure 3. Short Inhibitory Sequences Features
Figure 4. Gene Transfer Therapy Features
Figure 5. Nucleoside Analogs Features
Figure 6. Ribozymes Features
Figure 7. Aptamers Features
Figure 8. Global Nucleic Acid-based Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Monogenetic Disorders Case Studies
Figure 10. Multi-Genetic Disorders Case Studies
Figure 11. Nucleic Acid-based Therapeutics Report Years Considered
Figure 12. Global Nucleic Acid-based Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Nucleic Acid-based Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Nucleic Acid-based Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Nucleic Acid-based Therapeutics Market Share by Players in 2019
Figure 17. Global Top Nucleic Acid-based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nucleic Acid-based Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Nucleic Acid-based Therapeutics Revenue in 2019
Figure 19. North America Nucleic Acid-based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Nucleic Acid-based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Nucleic Acid-based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Nucleic Acid-based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Nucleic Acid-based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Nucleic Acid-based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Nucleic Acid-based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
核酸ラベリングの世界市場（～2026年） Nucleic acid labeling techniques has wide range of applications in Life sciences industry. Nucleic acid Labeling is mainly used to identify proteins, DNA and RNA by using various Labeling techniques. Based on the product, the market was segmented into reagents and kits and Services. Among them, reag…- 核酸増幅検査の世界市場（～2026年） Market Analysis and Insights: Global Nucleic Acid Amplification Testing Market The global Nucleic Acid Amplification Testing market size is projected to reach US$ 137.6 million by 2026, from US$ 131.5 million in 2020, at a CAGR of 4.3%% during 2021-2026. Global Nucleic Acid Amplification Testing Sco…
- ムコ多糖症（MPS）遺伝子治療の世界市場（～2026年） Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …
- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 加齢黄斑変性症（AMD）遺伝子治療の世界市場（～2026年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…